Rectal Cancer Clinical Trials in Wuhan, Hubei
15 recruitingWuhan, Hubei, China
Showing 1–15 of 15 trials
Recruiting
Phase 2
A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer
ChemotherapyRectal CancerRadiotherapy+1 more
Tao Zhang25 enrolled1 locationNCT07239466
Recruiting
Phase 3
A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Taizhou Hanzhong biomedical co. LTD190 enrolled63 locationsNCT05652894
Recruiting
Phase 2Phase 3
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Untreated, Unresectable, or Metastatic Colorectal Cancer
Bristol-Myers Squibb990 enrolled263 locationsNCT07221357
Recruiting
Phase 2
Neoadjuvant SHR-1701 Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
CRC (Colorectal Cancer)
Hong Qiu48 enrolled1 locationNCT07478731
Recruiting
AI-Based Prediction of Liver Metastasis in Colorectal Cancer (A Retrospective Study)
Colorectal Cancer Liver Metastases (CRLM)
Tongji Hospital1,500 enrolled1 locationNCT07399236
Recruiting
Prospective Validation of an AI Model for Predicting Liver Metastasis in Colorectal Cancer
Colorectal Cancer Liver Metastasis
Tongji Hospital160 enrolled1 locationNCT07392567
Recruiting
Phase 1Phase 2
A Study of GFH375 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors Harboring KRAS G12D Mutation
Advanced Solid Tumors CancerPDACCRC (Colorectal Cancer)
Genfleet Therapeutics (Shanghai) Inc.126 enrolled4 locationsNCT07259590
Recruiting
Phase 1Phase 2
TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in Chemotherapy-failed RAS/BRAF Wild-type Advanced Colorectal Cancer
RAS/BRAF Wild Type Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.72 enrolled27 locationsNCT07044908
Recruiting
Phase 1
A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor
Shanghai Junshi Bioscience Co., Ltd.214 enrolled13 locationsNCT06839105
Recruiting
Phase 1Phase 2
Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Liu Huang42 enrolled1 locationNCT06980532
Recruiting
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
Rectal CancerRectum CancerCancer of Rectum+4 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology152 enrolled2 locationsNCT03573791
Recruiting
Phase 2
Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy, HLX07and Serplulimab in LARC
Rectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology29 enrolled3 locationsNCT06542588
Recruiting
Not Applicable
Artificial Intelligence Assists Surgeons' Decision Making
Rectal Cancer
Jichao Qin616 enrolled1 locationNCT04999007
Recruiting
Not Applicable
Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
Metastatic Colorectal Cancer
Liu Huang80 enrolled1 locationNCT06551207
Recruiting
Not Applicable
Multicenter Study on Postoperative Urinary and Sexual Function During Laparoscopic Functional Total Mesorectum Excision
Rectal Cancer
Renmin Hospital of Wuhan University88 enrolled1 locationNCT05049317